Literature DB >> 24093757

Comparative analysis of differential network modularity in tissue specific normal and cancer protein interaction networks.

Md Fahmid Islam1, Md Moinul Hoque1, Rajat Suvra Banik1, Sanjoy Roy2, Sharmin Sultana Sumi1, Ahmad Ullah1, F M Nazmul Hassan1, Md Tauhid Siddiki Tomal1, K M Taufiqur Rahman1.   

Abstract

BACKGROUND: Large scale understanding of complex and dynamic alterations in cellular and subcellular levels during cancer in contrast to normal condition has facilitated the emergence of sophisticated systemic approaches like network biology in recent times. As most biological networks show modular properties, the analysis of differential modularity between normal and cancer protein interaction networks can be a good way to understand cancer more significantly. Two aspects of biological network modularity e.g. detection of molecular complexes (potential modules or clusters) and identification of crucial nodes forming the overlapping modules have been considered in this regard.
METHODS: In the current study, the computational analysis of previously published protein interaction networks (PINs) has been conducted to identify the molecular complexes and crucial nodes of the networks. Protein molecules involved in ten major cancer signal transduction pathways were used to construct the networks based on expression data of five tissues e.g. bone, breast, colon, kidney and liver in both normal and cancer conditions. MCODE (molecular complex detection) and ModuLand methods have been used to identify the molecular complexes and crucial nodes of the networks respectively.
RESULTS: In case of all tissues, cancer PINs show higher level of clustering (formation of molecular complexes) than the normal ones. In contrast, lower level modular overlapping is found in cancer PINs than the normal ones. Thus a proposition can be made regarding the formation of some giant nodes in the cancer networks with very high degree and resulting in reduced overlapping among the network modules though the predicted molecular complex numbers are higher in cancer conditions.
CONCLUSION: The study predicts some major molecular complexes that might act as the important regulators in cancer progression. The crucial nodes identified in this study can be potential drug targets to combat cancer.

Entities:  

Year:  2013        PMID: 24093757      PMCID: PMC3852839          DOI: 10.1186/2043-9113-3-19

Source DB:  PubMed          Journal:  J Clin Bioinforma        ISSN: 2043-9113


Background

Reductionist philosophy has directed biological research for decades [1,2]. A significant amount of information has been generated so far in the field of biological sciences as enrichment of human knowledgebase to understand life [1]. Despite enormous success of reductionism to decode the structural and functional attributes at cellular and molecular levels of life-organization, it is progressively becoming clearer that biological functions can rarely be credited to discrete perception of individual molecules. Alternatively, most biological phenomena emerge due to extremely interactive complexity derived from functional integrity of cell’s numerous constituents [2]. Various recent approaches have been initiated and accomplished to study biological systems in more integrative and comprehensive way. Network model can play an important role to understand the complex network system based on multiple sets of interactions and to make plain and clear analysis of the origin of observed network characteristics [3-7]. Network biology has thus come out at present time as a revolutionary approach for the empirical study to understand complex biological systems [3,8-12]. In cancer condition, genomic instability results in alterations of downstream signal transduction pathways and protein-protein interactions. Current understanding of the dynamic changes at genomic and proteomic levels indicates that cancer can be considered as a stochastic phenomenon rather than being the result of some specific linear alterations [13]. Insightful understanding of comparative regulatory patterns in normal and cancerous cells requires in detailed study of molecular interactions [14] and network biology has prospective usefulness in this regard [15]. The concepts of network biology can be utilized to decipher the differential interaction patterns between normal and cancer conditions through construction of biomolecular networks and subsequent in depth analysis of the networks. Studying modularity of biomolecular networks can be an efficient way to understand their inherent properties and identify the crucial molecular sets and components of the networks (which is a basic challenge of the study of these networks) [16]. In most of the cases biomolecular networks show modular organization that means the network can be divided into modules according to the density of connections among the nodes of a network. More specifically, modules are the subsets of a network that have comparatively high connectedness among the nodes (through the edges) forming the modules. The modules have lots of connections within themselves but sparse connections among them [17,18]. From a general point of view, depiction of the modules is useful in understanding the structural and functional features of networks, which has stimulated many empirical researches as well as practical applications e.g. protein complex and drug target identification [19,20]. The main objective of this paper was to study the differential modularity patterns of normal and cancer protein interaction networks (PINs). The PINs were constructed for five tissues e.g. bone, breast, colon, kidney and liver in both normal and cancer conditions [21]. The network construction was based on expression data of protein molecules participating in ten major cancer signal transduction pathways. MCODE (molecular complex detection) [22] method was used to identify and analyze potential molecular complexes (modules or clusters) of the networks. Another method ModuLand [23,24] was used for identification and subsequent analysis of crucial nodes forming overlapping modules of the networks.

Methods

The primary data required were retrieved from differential expression database GeneHub-GEPIS (an online bioinformatics tool for inferring gene expression patterns in a large panel of normal and cancer tissues; http://research-public.gene.com/Research/genentech/genehub-gepis/index.html) [25] and protein-protein interaction prediction tools e.g. PIPs (Human Protein-Protein Interaction Prediction; http://www.compbio.dundee.ac.uk/www-pips/) [26,27] and STRING (a database of known and predicted protein interactions; http://string.embl.de/) [28-33]. Cytoscape software package [34-36] was used to construct protein interaction networks (PINs) (Additional files 1 and 2) [21]. For modularity analysis two Cytoscape plugins namely MCODE and ModuLand were used. MCODE was used to identify and rank all possible molecular complexes of particular networks and ModuLand was used to identify crucial nodes forming the overlapping modules in those networks. MCODE detects densely connected regions in large protein interaction networks, which may be characterized as molecular complexes [22]. The MCODE method stands on vertex weighting by local neighborhood density and outward traversal from a locally dense seed protein to isolate the dense regions according to given parameters. The ModuLand method provides an algorithm for determining extensively overlapping network modules [23,24]. Additionally, it identifies several hierarchical layers of modules through representation of modules of the lower layer by meta-nodes of the higher hierarchical layer. This method predicts the function of the whole module and determines key nodes bridging two or multiple modules through assigning module cores. During MCODE and ModuLand analysis default parameter values were utilized. The default MCODE set up was fixed like, Find Clusters: in Whole Network; Network Scoring (Advanced Option)- a) Include Loops: Turn off, b) Degree Cutoff: 2; Cluster Finding- a) Haircut: Turn on, b) Fluff: Turn off, c) Node Score Cutoff: 0.2, d) K-Core: 2, e) Max. Depth: 100. During ModuLand analysis, selected unweighted network option was taken with default value 1. ModuLand was run to identify and visualize overlapping modules and merged (for modules) with threshold value 1.0 to create correlation matrix of original modularization and module correlation histogram. Measures option of ModuLand was used to calculate the graph related parameters of the overlapping modules.

Results and discussion

Molecular complex detection

Molecular complex detection (MCODE) method has been used to evaluate yeast protein interaction compilation using known molecular complex data from mass spectrometry of the proteome [19,37]. This leads to the observation that highly interconnected, or dense regions of the network may represent molecular complexes [38]. The numbers of possible modules that can be said as molecular complexes, differ between normal and cancer conditions in each of the five tissues (Figures 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10). The ranked molecular complex numbers of normal and cancer protein interaction networks are 15 and 19 for bone, 22 and 28 for breast, 22 and 27 for colon, 21 and 30 for kidney and 19 and 28 for liver respectively (Figures 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10). In all cases, possible molecular complex numbers increase in cancer condition. The statistical significance test also supports the difference (at p ≤ 0.05) and depicts that the molecular complex numbers of cancer PINs are significantly increased than the normal PINs (at p = 0.02) (Additional file 3).
Figure 1

MCODE analysis of normal condition protein interaction network in bone.

Figure 2

MCODE analysis of cancer condition protein interaction network in bone.

Figure 3

MCODE analysis of normal condition protein interaction network in breast.

Figure 4

MCODE analysis of cancer condition protein interaction network in breast.

Figure 5

MCODE analysis of normal condition protein interaction network in colon.

Figure 6

MCODE analysis of cancer condition protein interaction network in colon.

Figure 7

MCODE analysis of normal condition protein interaction network in kidney.

Figure 8

MCODE analysis of cancer condition protein interaction network in kidney.

Figure 9

MCODE analysis of normal condition protein interaction network in liver.

Figure 10

MCODE analysis of cancer condition protein interaction network in liver.

MCODE analysis of normal condition protein interaction network in bone. MCODE analysis of cancer condition protein interaction network in bone. MCODE analysis of normal condition protein interaction network in breast. MCODE analysis of cancer condition protein interaction network in breast. MCODE analysis of normal condition protein interaction network in colon. MCODE analysis of cancer condition protein interaction network in colon. MCODE analysis of normal condition protein interaction network in kidney. MCODE analysis of cancer condition protein interaction network in kidney. MCODE analysis of normal condition protein interaction network in liver. MCODE analysis of cancer condition protein interaction network in liver. Kidney cancer shows highest increment during cancer in comparison to normal state for predicted molecular complex numbers (Figures 7 and 8). Not only the molecular complex numbers, all other parameters e.g. scores, nodes and edges of the molecular complex networks differ between normal and cancer conditions for each tissue (Figures 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 and Additional file 4). As in case of cancer networks, the related edge and node numbers increase from the normal conditions for all five tissues, the overall clustering is also enhanced in cancer networks. The normal and cancer networks were mainly constructed based on the expression and interaction data of protein molecules participating in major cancer signal transduction pathways which has been described in our previous paper [21]. The event of increased edges and nodes in cancer tissues compared with normal tissues can be explained as the enhancement of molecular interactions at proteomic level in cancer states in comparison to normal states. It is mentionable that the graphical representations of such differences are based on already validated experimental data regarding gene expression and protein interaction. The biological meaning of the observed differences seems to be very obvious indicating that cancer tissue involves more proteins to interact with each other during cancer signaling. A current report supports that disease genes tend to have higher degree and connectivity in comparison to non-disease genes in terms of expression and interaction of proteins [39]. Some studies also indicate that proteins encoded by cancer genes can interact strongly with other proteins and show higher connectivity than normal condition [40]. There is also evidence of overrepresentation of 10% of protein interaction clusters within the cancer interactome when compared to the normal protein interaction networks [7].

Overlapping module and crucial node identification from the networks

In case of bone, overlapping module is present in normal condition but absent in cancer (Figure 11). Overlapping modules between normal and cancer states differ for all other tissues (Figures 12, 13, 14, 15, 16, 17, 18 and 19). In breast, kidney and liver edge and node numbers decrease in cancer and most of the molecules forming the overlapping networks are changed (Figures 12, 13, 16, 17, 18 and 19). In colon, edge and node numbers remain constant but most of the molecules forming the overlapping modules are altered (Figures 14, 15). The highest fluctuation of overlapping module from the point of node and edge number and molecules forming the overlapping networks occurs in case of kidney (Figures 16, 17). The nodes of the overlapping module can be said as the crucial nodes with module centrality (which is the central node of the related modules formed by ModuLand) of the respective network [41]. The important network properties of the overlapping modules have been compared in Tables 1, 2, 3, 4, 5, 6, 7, 8 and 9.
Figure 11

Overlapping module in normal condition of bone.

Figure 12

Overlapping module in normal condition of breast.

Figure 13

Overlapping module in cancer condition of breast.

Figure 14

Overlapping module in normal condition of colon.

Figure 15

Overlapping module in cancer condition of colon.

Figure 16

Overlapping module in normal condition of kidney.

Figure 17

Overlapping module in cancer condition of kidney.

Figure 18

Overlapping module in normal condition of liver.

Figure 19

Overlapping module in cancer condition of liver.

Table 1

Graph related parameters for normal condition of bone

NodeIDEffective degreeModuLand community centralityBetweenness centralityModuLand overlapModuLand bridgeness
SMAD3
1
32.76882
0
1
0
PSMD1132.76882010
Table 2

Graph related parameters for normal condition of breast

NodeIDEffective degreeModuLand community centralityBetweenness centralityModuLand overlapModuLand bridgeness
SMAD2
2.579363
564.9435
0
1
0
NRAS
1.450132
87.90458
0
1
0
PSMD12
2.022537
464.4288
0
1
0
SNX1
2.999741
13.47424
0
1
0
TCF4
0
0
0
1
0
NCK00010
Table 3

Graph related parameters for cancer condition of breast

NodeIDEffective degreeModuLand community centralityBetweenness centralityModuLand overlapModuLand bridgeness
SMAD2
2
325.3334
0
1
0
NRAS
2
79.67153
0
1
0
TAB22245.9151010
Table 4

Graph related parameters for normal condition of colon

NodeIDEffective degreeModuLand community centralityBetweenness centralityModuLand overlapModuLand bridgeness
STAT1
2.239262
6792.052
0
1
0
SMAD2
2.650014
6520.055
0
1
0
TRADD
2.68063
255.6004
0
1
0
NRAS
1.443442
91.6213
0
1
0
GAPDH00010
Table 5

Graph related parameters for cancer condition of colon

NodeIDEffective degreeModuLand community centralityBetweenness centralityModuLand overlapModuLand bridgeness
FYN
2.792082
486.4563
0
1
0
NRAS
2.049608
130.5231
0
1
0
DLL1
1.730402
326.6208
0
1
0
KRT7
1.003324
29.61218
0
1
0
GAPDH00010
Table 6

Graph related parameters for normal condition of kidney

NodeIDEffective degreeModuLand community centralityBetweenness centralityModuLand overlapModuLand bridgeness
STAT5A
2.657912
51156.29
0
1
0
SMAD2
6.401464
50932.09
0
1
0
PSMD12
5.006495
1121.599
0
1
0
NRAS
6.620978
168.6027
0
1
0
ID3
4.308711
264.494
0
1
0
NCOA3
7.118026
258.9439
0
1
0
MYC
3.992952
421.0773
0
1
0
CSNK1D
2.100971
121.4912
0
1
0
ANKRD6
2.618028
66.80382
0
1
0
KRT7
0
0
0
1
0
POLR1B00010
Table 7

Graph related parameters for cancer condition of kidney

NodeIDEffective degreeModuLand community centralityBetweenness centralityModuLand overlapModuLand bridgeness
FYN
2
125.7711
0
1
0
NRAS
2
107.3406
0
1
0
KRT7218.65667010
Table 8

Graph related parameters for normal condition of liver

NodeIDEffective degreeModuLand community centralityBetweenness centralityModuLand overlapModuLand bridgeness
STAT1
2.86861
652.5232
0
1
0
NRAS
2.303882
214.573
0
1
0
PSMC2
2.009952
394.8492
0
1
0
POLR2H2.00656367.90855010
Table 9

Graph related parameters for cancer condition of liver

NodeIDEffective degreeModuLand community centralityBetweenness centralityModuLand overlapModuLand bridgeness
SMAD2
1
105.1724
0
0
1
NRAS1105.1724001
Overlapping module in normal condition of bone. Overlapping module in normal condition of breast. Overlapping module in cancer condition of breast. Overlapping module in normal condition of colon. Overlapping module in cancer condition of colon. Overlapping module in normal condition of kidney. Overlapping module in cancer condition of kidney. Overlapping module in normal condition of liver. Overlapping module in cancer condition of liver. Graph related parameters for normal condition of bone Graph related parameters for normal condition of breast Graph related parameters for cancer condition of breast Graph related parameters for normal condition of colon Graph related parameters for cancer condition of colon Graph related parameters for normal condition of kidney Graph related parameters for cancer condition of kidney Graph related parameters for normal condition of liver Graph related parameters for cancer condition of liver Correlation matrix and correlation histogram in both normal and cancer conditions for each tissue represent the nature of correlation among the nodes of the overlapping modules (Tables 10, 11, 12, 13, 14, 15, 16, 17 and 18 and Figures 20, 21, 22, 23, 24, 25, 26, 27 and 28). Correlation matrix represents all the possible interactions of the overlapping modules. Correlation histogram represents only the valid interactions at certain threshold (here 1.0). From the correlation matrix and histogram, it is found that the interactions among the nodes of overlapping modules differ between normal and cancer cases (Tables 10, 11, 12, 13, 14, 15, 16, 17 and 18 and Figures 20, 21, 22, 23, 24, 25, 26, 27 and 28). The statistical significance test also supports the difference (at p ≤ 0.1) and depicts that valid interactions (at threshold 1.0) of overlapping modules in cancer PINs are significantly increased than the normal PINs (at p = 0.08) (Additional file 3).
Table 10

Correlation matrix for normal condition of bone

 SMAD3PSMD1
SMAD3
1
-0.24068
PSMD1-0.240681
Table 11

Correlation matrix for normal condition of breast

 SMAD2NRASPSMD12SNX1TCF4NCK
SMAD2
1
-0.03436
-0.20478
0.024483
-0.13341
-0.13341
NRAS
-0.03436
1
0.520993
0.053684
-0.11923
-0.11923
PSMD12
-0.20478
0.520993
1
-0.0323
-0.09971
-0.09971
SNX1
0.024483
0.053684
-0.0323
1
-0.01227
-0.01227
TCF4
-0.13341
-0.11923
-0.09971
-0.01227
1
-0.00608
NCK-0.13341-0.11923-0.09971-0.01227-0.006081
Table 12

Correlation matrix for cancer condition of breast

 SMAD2NRASTAB2
SMAD2
1
-0.0843
-0.14403
NRAS
-0.0843
1
0.453856
TAB2-0.144030.4538561
Table 13

Correlation matrix for normal condition of colon

 STAT1SMAD2TRADDNRASGAPDH
STAT1
1
0.345955
0.03459
0.01538
-0.1398
SMAD2
0.345955
1
0.219089
0.011785
-0.13841
TRADD
0.03459
0.219089
1
0.252983
-0.11925
NRAS
0.01538
0.011785
0.252983
1
-0.09299
GAPDH-0.1398-0.13841-0.11925-0.092991
Table 14

Correlation matrix for cancer condition of colon

 FYNNRASDLL1KRT7GAPDH
FYN
1
-0.03623
-0.11094
-0.09958
-0.10397
NRAS
-0.03623
1
0.302796
0.126064
-0.09173
DLL1
-0.11094
0.302796
1
0.014064
-0.06608
KRT7
-0.09958
0.126064
0.014064
1
-0.01448
GAPDH-0.10397-0.09173-0.06608-0.014481
Table 15

Correlation matrix for normal condition of kidney

 STAT5ASMAD2PSMD12NRASID3NCOA3MYCCSNK1DANKRD6KRT7POLR1B
STAT5A
1
0.865947
0.066442
0.144672
0.035023
0.026829
0.039755
-0.17473
-0.22182
-0.13318
-0.16338
SMAD2
0.865947
1
0.085819
0.110893
0.020009
0.026779
0.026134
-0.1123
-0.1689
-0.13318
-0.16338
PSMD12
0.066442
0.085819
1
0.491691
0.276862
0.255873
0.253694
-0.04079
-0.16593
-0.12014
-0.14737
NRAS
0.144672
0.110893
0.491691
1
0.275515
0.246432
0.265387
-0.06826
-0.14946
-0.09565
-0.11733
ID3
0.035023
0.020009
0.276862
0.275515
1
0.983226
0.98228
-0.02846
-0.02835
-0.08511
-0.1044
NCOA3
0.026829
0.026779
0.255873
0.246432
0.983226
1
0.987846
0.013256
-0.0074
-0.08704
-0.10677
MYC
0.039755
0.026134
0.253694
0.265387
0.98228
0.987846
1
-0.01465
-0.02672
-0.0882
-0.1082
CSNK1D
-0.17473
-0.1123
-0.04079
-0.06826
-0.02846
0.013256
-0.01465
1
0.422071
-0.02188
-0.02685
ANKRD6
-0.22182
-0.1689
-0.16593
-0.14946
-0.02835
-0.0074
-0.02672
0.422071
1
-0.02344
-0.02876
KRT7
-0.13318
-0.13318
-0.12014
-0.09565
-0.08511
-0.08704
-0.0882
-0.02188
-0.02344
1
-0.00784
POLR1B-0.16338-0.16338-0.14737-0.11733-0.1044-0.10677-0.1082-0.02685-0.02876-0.007841
Table 16

Correlation matrix for cancer condition of kidney

 FYNNRASKRT7
FYN
1
0.094025
-0.08621
NRAS
0.094025
1
0.062247
KRT7-0.086210.0622471
Table 17

Correlation matrix for normal condition of liver

 STAT1NRASPSMC2POLR2H
STAT1
1
-0.00568
-0.14947
-0.19596
NRAS
-0.00568
1
0.374997
-0.17413
PSMC2
-0.14947
0.374997
1
0.173069
POLR2H-0.19596-0.174130.1730691
Table 18

Correlation matrix for cancer condition of liver

 SMAD2NRAS
SMAD2
1
0.438329
NRAS0.4383291
Figure 20

Correlation histogram for normal condition of bone.

Figure 21

Correlation histogram for normal condition of breast.

Figure 22

Correlation histogram for cancer condition of breast.

Figure 23

Correlation histogram for normal condition of colon.

Figure 24

Correlation histogram for cancer condition of colon.

Figure 25

Correlation histogram for normal condition of kidney.

Figure 26

Correlation histogram for cancer condition of kidney.

Figure 27

Correlation histogram for normal condition of liver.

Figure 28

Correlation histogram for cancer condition of liver.

Correlation matrix for normal condition of bone Correlation matrix for normal condition of breast Correlation matrix for cancer condition of breast Correlation matrix for normal condition of colon Correlation matrix for cancer condition of colon Correlation matrix for normal condition of kidney Correlation matrix for cancer condition of kidney Correlation matrix for normal condition of liver Correlation matrix for cancer condition of liver Correlation histogram for normal condition of bone. Correlation histogram for normal condition of breast. Correlation histogram for cancer condition of breast. Correlation histogram for normal condition of colon. Correlation histogram for cancer condition of colon. Correlation histogram for normal condition of kidney. Correlation histogram for cancer condition of kidney. Correlation histogram for normal condition of liver. Correlation histogram for cancer condition of liver. In case of bone, there is no correlation matrix and correlation histogram for cancer as there is no overlapping module (Table 10; Figure 20). Correlation matrix and correlation histogram show reduced number of interactions during cancer in case of breast, kidney and liver (Tables 11, 12, 15, 16, 17, and 18; Figures 21, 22, 25, 26, 27 and 28). In case of colon, the interaction number remains the same (Tables 13, 14; Figures 23, 24). The correlation frequency in the histograms fluctuates between two conditions as the molecules representing the nodes of overlapping modules differ (Figures 20, 21, 22, 23, 24, 25, 26, 27 and 28). The crucial nodes identified from the overlapping modules are found to show important biological signification in recently reconstructed high-quality Staphylococcus aureus metabolic network model [41-43]. Identification of functional subgraphs from cancer protein interaction networks representing the important modules and their components has been a key issue in some papers [44,45]. The parameter values used for MCODE and ModuLand analysis remained the same for both normal and cancer state study and were applied according to the suggested range by plugin developers. So it can be assumed that the parameter values have not any significant effect on the conclusions. It can be also said that some minor effects of parameter values may have some influence but these will not affect our understanding of qualitative comparison between normal and cancer PINs. The MCODE study shows that during cancer condition in each tissue, network clustering is increased. The ModuLand study denotes that the crucial nodes with module centrality are decreased in cancer (except breast cancer) representing the reduced level of module overlapping of cancer networks. The possible reason can be explained by degree distribution of the networks (Figures 29, 30, 31, 32, 33, 34, 35, 36, 37 and 38). Degree distribution of the networks can account for a possible explanation for counter behaving such clustering and overlapping. In all cancer PINs, few selective nodes with much higher degree are found contrary to the normal PINs. From this observation, a plausible argument can be proposed that some giant nodes are formed in cancer PINs covering a huge degree number and result in many randomly dispersed nodes. Such instance reduces the number of nodes with module centrality and subsequently overlapping modules with reduced number of nodes and edges are formed.
Figure 29

Degree distribution in bone normal network.

Figure 30

Degree distribution in bone cancer network.

Figure 31

Degree distribution in breast normal network.

Figure 32

Degree distribution in breast cancer network.

Figure 33

Degree distribution in colon normal network.

Figure 34

Degree distribution in colon cancer network.

Figure 35

Degree distribution in kidney normal network.

Figure 36

Degree distribution in kidney cancer network.

Figure 37

Degree distribution in liver normal network.

Figure 38

Degree distribution in liver cancer network.

Degree distribution in bone normal network. Degree distribution in bone cancer network. Degree distribution in breast normal network. Degree distribution in breast cancer network. Degree distribution in colon normal network. Degree distribution in colon cancer network. Degree distribution in kidney normal network. Degree distribution in kidney cancer network. Degree distribution in liver normal network. Degree distribution in liver cancer network.

Conclusion

The study gives us a clear picture of the differential modular nature between normal and cancer protein interaction networks. Normal and cancer protein interaction networks (PINs) show observable differences in case of both molecular complex and crucial node identification. The cancer PINs show higher predicted clustering but lower overlapping of network modules in contrast to the normal ones. The changes in predicted molecular complexes between normal and cancer PINs can be a handy tool to decipher the conversion of normal cells to cancer cells. The major molecular complexes (higher ranked) resulted from this study can be merged with experimental evidences to identify the core regulators responsible for cancer enigma. The identified crucial nodes can be recommended as potential drug targets against cancer and can be further assessed with experimental studies. This study can be further intensified through the inclusion of whole proteomic networks for normal and cancer cells derived from high throughput proteomic methods and their subsequent analysis by comprehensive computational tools. The networks considered here are unweighted and static which makes it less reliable to understand the real dynamic physical nature of living tissues. So it requires further expedition to comprehend the dynamics as well as to overcome the present limitations of network level understanding of biological processes. Moreover, the protein interaction study has to be merged with corresponding gene regulatory networks to draw more authentic conclusion regarding predicted modularity.

Competing interests

The authors declare that they have no competing interests.

Additional file 1

Differential protein interaction networks for normal and cancer tissues. Click here for file

Additional file 2

Expression and interaction data related to normal and cancer conditions of five tissues. Click here for file

Additional file 3

Tables for statistical significant test. Click here for file

Additional file 4

List of proteins of molecular complexes in normal and cancer protein interaction networks. Click here for file
  30 in total

1.  Systems biology. Life's complexity pyramid.

Authors:  Zoltán N Oltvai; Albert-László Barabási
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

Review 2.  Network biology: understanding the cell's functional organization.

Authors:  Albert-László Barabási; Zoltán N Oltvai
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

3.  Integration of biological networks and gene expression data using Cytoscape.

Authors:  Melissa S Cline; Michael Smoot; Ethan Cerami; Allan Kuchinsky; Nerius Landys; Chris Workman; Rowan Christmas; Iliana Avila-Campilo; Michael Creech; Benjamin Gross; Kristina Hanspers; Ruth Isserlin; Ryan Kelley; Sarah Killcoyne; Samad Lotia; Steven Maere; John Morris; Keiichiro Ono; Vuk Pavlovic; Alexander R Pico; Aditya Vailaya; Peng-Liang Wang; Annette Adler; Bruce R Conklin; Leroy Hood; Martin Kuiper; Chris Sander; Ilya Schmulevich; Benno Schwikowski; Guy J Warner; Trey Ideker; Gary D Bader
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  Functional organization of the yeast proteome by systematic analysis of protein complexes.

Authors:  Anne-Claude Gavin; Markus Bösche; Roland Krause; Paola Grandi; Martina Marzioch; Andreas Bauer; Jörg Schultz; Jens M Rick; Anne-Marie Michon; Cristina-Maria Cruciat; Marita Remor; Christian Höfert; Malgorzata Schelder; Miro Brajenovic; Heinz Ruffner; Alejandro Merino; Karin Klein; Manuela Hudak; David Dickson; Tatjana Rudi; Volker Gnau; Angela Bauch; Sonja Bastuck; Bettina Huhse; Christina Leutwein; Marie-Anne Heurtier; Richard R Copley; Angela Edelmann; Erich Querfurth; Vladimir Rybin; Gerard Drewes; Manfred Raida; Tewis Bouwmeester; Peer Bork; Bertrand Seraphin; Bernhard Kuster; Gitte Neubauer; Giulio Superti-Furga
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

5.  A comparative study of cancer proteins in the human protein-protein interaction network.

Authors:  Jingchun Sun; Zhongming Zhao
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

6.  Global landscape of protein complexes in the yeast Saccharomyces cerevisiae.

Authors:  Nevan J Krogan; Gerard Cagney; Haiyuan Yu; Gouqing Zhong; Xinghua Guo; Alexandr Ignatchenko; Joyce Li; Shuye Pu; Nira Datta; Aaron P Tikuisis; Thanuja Punna; José M Peregrín-Alvarez; Michael Shales; Xin Zhang; Michael Davey; Mark D Robinson; Alberto Paccanaro; James E Bray; Anthony Sheung; Bryan Beattie; Dawn P Richards; Veronica Canadien; Atanas Lalev; Frank Mena; Peter Wong; Andrei Starostine; Myra M Canete; James Vlasblom; Samuel Wu; Chris Orsi; Sean R Collins; Shamanta Chandran; Robin Haw; Jennifer J Rilstone; Kiran Gandi; Natalie J Thompson; Gabe Musso; Peter St Onge; Shaun Ghanny; Mandy H Y Lam; Gareth Butland; Amin M Altaf-Ul; Shigehiko Kanaya; Ali Shilatifard; Erin O'Shea; Jonathan S Weissman; C James Ingles; Timothy R Hughes; John Parkinson; Mark Gerstein; Shoshana J Wodak; Andrew Emili; Jack F Greenblatt
Journal:  Nature       Date:  2006-03-22       Impact factor: 49.962

7.  Cytoscape 2.8: new features for data integration and network visualization.

Authors:  Michael E Smoot; Keiichiro Ono; Johannes Ruscheinski; Peng-Liang Wang; Trey Ideker
Journal:  Bioinformatics       Date:  2010-12-12       Impact factor: 6.937

8.  STRING 8--a global view on proteins and their functional interactions in 630 organisms.

Authors:  Lars J Jensen; Michael Kuhn; Manuel Stark; Samuel Chaffron; Chris Creevey; Jean Muller; Tobias Doerks; Philippe Julien; Alexander Roth; Milan Simonovic; Peer Bork; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

9.  Cluster analysis of networks generated through homology: automatic identification of important protein communities involved in cancer metastasis.

Authors:  Pall F Jonsson; Tamara Cavanna; Daniel Zicha; Paul A Bates
Journal:  BMC Bioinformatics       Date:  2006-01-06       Impact factor: 3.169

10.  GeneHub-GEPIS: digital expression profiling for normal and cancer tissues based on an integrated gene database.

Authors:  Yan Zhang; Shiuh-Ming Luoh; Lawrence S Hon; Robert Baertsch; William I Wood; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2007-06-01       Impact factor: 16.971

View more
  10 in total

Review 1.  Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity.

Authors:  Daniel V T Catenacci
Journal:  Mol Oncol       Date:  2014-10-18       Impact factor: 6.603

2.  Network and matrix analysis of the respiratory disease interactome.

Authors:  Benjamin Garcia; Gargi Datta; Gregory P Cosgrove; Michael Strong
Journal:  BMC Syst Biol       Date:  2014-03-22

Review 3.  Gene regulatory networks and their applications: understanding biological and medical problems in terms of networks.

Authors:  Frank Emmert-Streib; Matthias Dehmer; Benjamin Haibe-Kains
Journal:  Front Cell Dev Biol       Date:  2014-08-19

Review 4.  Genetic tests in major psychiatric disorders-integrating molecular medicine with clinical psychiatry-why is it so difficult?

Authors:  U Demkow; T Wolańczyk
Journal:  Transl Psychiatry       Date:  2017-06-13       Impact factor: 6.222

5.  Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks.

Authors:  Evgeny Gladilin
Journal:  PLoS One       Date:  2017-01-31       Impact factor: 3.240

6.  Systematic Analysis of Differential Expression Profile in Rheumatoid Arthritis Chondrocytes Using Next-Generation Sequencing and Bioinformatics Approaches.

Authors:  Yi-Jen Chen; Wei-An Chang; Ling-Yu Wu; Ya-Ling Hsu; Chia-Hsin Chen; Po-Lin Kuo
Journal:  Int J Med Sci       Date:  2018-07-13       Impact factor: 3.738

7.  Sparse Regression in Cancer Genomics: Comparing Variable Selection and Predictions in Real World Data.

Authors:  Robert J O'Shea; Sophia Tsoka; Gary Jr Cook; Vicky Goh
Journal:  Cancer Inform       Date:  2021-11-27

Review 8.  Overview of methods for characterization and visualization of a protein-protein interaction network in a multi-omics integration context.

Authors:  Vivian Robin; Antoine Bodein; Marie-Pier Scott-Boyer; Mickaël Leclercq; Olivier Périn; Arnaud Droit
Journal:  Front Mol Biosci       Date:  2022-09-08

9.  Gene expression correlation for cancer diagnosis: a pilot study.

Authors:  Binbing Ling; Lifeng Chen; Qiang Liu; Jian Yang
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

10.  Computational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer.

Authors:  Daniela Börnigen; Svitlana Tyekucheva; Xiaodong Wang; Jennifer R Rider; Gwo-Shu Lee; Lorelei A Mucci; Christopher Sweeney; Curtis Huttenhower
Journal:  PLoS Comput Biol       Date:  2016-04-14       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.